Download PDF
Thromb Haemost 1990; 63(02): 169-173
DOI: 10.1055/s-0038-1645039
Original Article
Schattauer GmbH Stuttgart

Crossreactivity of Antibodies Directed against Cardiolipin, DNA, Endothelial Cells and Blood Platelets

Paula Hasselaar
2   The Department of Haematology, University Hospital Utrecht, The Netherlands
2   The Department of Internal Medicine (Division of Immunopathology), University Hospital Utrecht, The Netherlands
,
Ronald H W M Derksen
2   The Department of Internal Medicine (Division of Immunopathology), University Hospital Utrecht, The Netherlands
,
Laya Blokzijl
2   The Department of Haematology, University Hospital Utrecht, The Netherlands
2   The Department of Internal Medicine (Division of Immunopathology), University Hospital Utrecht, The Netherlands
,
Philip G de Groot
2   The Department of Haematology, University Hospital Utrecht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 07 July 1989

Accepted after revision 04 December 1989

Publication Date:
02 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The interrelationship of antibodies directed against cardiolipin (CL), double stranded DNA (dsDNA), endothelial cells (EC) and blood platelets was investigated. IgG fractions, reactive with these antigens, were isolated from the plasmas from 8 patients with systemic lupus erythematosus and tested for crossreactivity with anionic phospholipids (CL, phosphatidylserine, phos-phatidylinositol), zwitterionic phospholipids (phosphatidyl-ethanolamine, phosphatidylcholine), dsDNA, EC and platelets by enzyme-linked immunosorbent assays and for lupus anticoagulant (LAC) activity with a coagulation assay.

Our results demonstrate the frequent occurrence of crossreactivity between antibodies to anionic phospholipids, EC and platelets. Crossreactivities between these antibodies and antibodies to dsDNA or zwitterionic phospholipids are exceptional. LAC activity was found in the anti-CL, anti-EC and anti-platelet fractions of only one patient. These findings support the hypothesis that subpopulations of antibodies directed against negatively charged phospholipids can bind to EC and blood platelets, which may have implications for the pathogenetic potential of antiphospholipid antibodies.

 

  • References

  • 1 Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-young CG, Loizou S, Hughes GR V. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupuserythematosus. Lancet 1983; 2: 1211-1214
    PubMedGoogle Scholar
  • 2 Derksen RH W M, Kater L. Lupus anticoagulant: revival of an old phenomenon. Clin Exp Rheumatol 1985; 3: 349-357
    PubMedGoogle Scholar
  • 3 Feinstein DI. Lupus anticoagulant, thrombosis and fetal loss. N Engl J Med 1985; 313: 1348-1350
    CrossrefPubMedGoogle Scholar
  • 4 Derksen RH W M, Bouma BN, Kater L. The striking association between lupus anticoagulant and fetal loss in systemic lupus erythematosus. Arthritis Rheum 1986; 29: 695-696
    PubMedGoogle Scholar
  • 5 Lechner K, Pabinger-Fasching I. Lupus anticoagulants and thrombosis. Haemostasis 1985; 15: 254-262
    PubMedGoogle Scholar
  • 6 Shapiro SS, Thiagarajan P. Lupus anticoagulants. Prog Hemostas Thromb 1982; 6: 263-286
    PubMedGoogle Scholar
  • 7 Pengo V, Thiagarajan P, Shapiro SS, Heine MJ. Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 1987; 70: 69-76
    PubMedGoogle Scholar
  • 8 Harris EN, Gharavi AE, Loizou S, Derue G, Chan JK, Patel BM, Mackworth-Young CG, Bunn CC, Hughes GR V. Crossreactivity of antiphospholipid antibodie. J Clin Lab Immunol 1985; 16: 1-6
    PubMedGoogle Scholar
  • 9 Lafer EM, Rauch J, Andrezejewski C. et al Pulyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 1981; 153: 897-909
    CrossrefPubMedGoogle Scholar
  • 10 Harris EN, Gharavi AE, Tincani A, Chan KH, Englert H, Mantelli P, Allegro F, Ballestrieri HE, Hughes GR V. Affinity purified anticardiolipinand anti-DNA antibodies. J Clin Lab Immunol 1985; 17: 155-162
    PubMedGoogle Scholar
  • 11 shoenfeld Y, Rauch J, Massicotte H, Datta SK, Andre-Schwarz J, Stollar BD, Schwarz RS. Polyspecificity of monoclonal auto antibodies produced by human-human hybridomas. N Engl J Med 1983; 308: 414-420
    CrossrefPubMedGoogle Scholar
  • 12 Koike T, Tomioka H, Kumagai A. Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus. Clin Exp Immunol 1982; 50: 298-302
    PubMedGoogle Scholar
  • 13 Colaco CB, Male DK. Anti phospholipid antibodies in sy^philis and a thrombotic subset of SLE: distinct profiles of epitope specificity. Clin Exp Immunol 1985; 59: 449-456
    PubMedGoogle Scholar
  • 14 Koiker T, Sueishi M, Funaki H, Tomioka H, Yoshida S. Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984; 56: 193-199
    PubMedGoogle Scholar
  • 15 Vismara A, Meroni PL, Tincani A. et al Relationship between anticardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 1988; 74: 247-253
    PubMedGoogle Scholar
  • 16 Tan EM, Cohen AS, Fries JF. et al The 1982 revised criteria for theclassification of SLE. Arthritis Rheum 1982; 25: 1271-1277
    CrossrefPubMedGoogle Scholar
  • 17 Derksen RH W M, Hasselaar P, Blokziji L, Gmelig Meyling FH J, de Groot PG. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subsetof lupus patients. Ann Rheum Dis 1988; 47: 364-371
    CrossrefPubMedGoogle Scholar
  • 18 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-2756
    CrossrefPubMedGoogle Scholar
  • 19 Willems C, Astaldi GC B, de Groot PG. et al Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth musclecells. Exp Cell Res 1982; 139: 191-197
    CrossrefPubMedGoogle Scholar
  • 20 Hasselaar P, Triplett DA, LaRue A, Derksen RH W M, Blokziji L, de Groot PG, Wagenknecht DR, McIntyre JA. Heat treatment of serum and plasma induces false positive results in the antiphospholipid antibody ELISA. J Rheumatol (in press)..
    PubMedGoogle Scholar
  • 21 Smeenk RJ T, Lucassen WA M, Swaak TJ G. Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity. Arthritis Rheum 1987; 30: 607-617
    CrossrefPubMedGoogle Scholar
  • 22 Hasselaar P, Derksen RH W M, Oosting JD, Blokziji L, de Groot PG. Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cells. Thromb Haemo-stas 1989; 62: 654-660
    PubMedGoogle Scholar
  • 23 Khamashta MA, Harris EN, Gharavi AE, Derue G, Gil A, Vazquez JJ, Hughes GR V. Immune mediated mechanism for thrombosis:antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 1988; 47: 849-854
    CrossrefPubMedGoogle Scholar
  • 24 Staub HL, Harris EN, Khamashta MA, Savidge G, Chahade WH, hughes GR V. Antibody to phosphatidylethanolamine in a patient with lupus anticoagulantand thrombosis. Ann Rheum Dis 1989; 48: 166-169
    CrossrefPubMedGoogle Scholar
  • 25 Rauch J, Tannenbaum H, Ramelson H, Cullis PR, Tilcock CP S, Hope MJ, Janoff AS. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem 1986; 261: 9672-9677
    PubMedGoogle Scholar
  • 26 Rosenbaum J, Pottinger BE, Woo P, Black CM, Loizou S, Byron MA, Pearson JD, Bassett MD. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988; 72: 450-456
    PubMedGoogle Scholar
  • 27 Harris EN, Asherson RA, Gharavi AE, Morgan SH, Derue G, Hughes GR V. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol 1985; 59: 227-230
    CrossrefPubMedGoogle Scholar
  • 28 Harris EN, Gharavi AE, Hedge U. et al Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 1985; 58: 231-234
    PubMedGoogle Scholar
  • 29 McEver RP, Martin MN. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984; 259: 9799-9805
    PubMedGoogle Scholar
  • 30 Nieuwenhuis HK, van Oosterhout JJ G, Rozemuller E, van Iwaarden F, Sixma JJ. Studies with a monoclonal antibody against activated platelets. Evidence that a secreted 53000 molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987; 70: 838-845
    PubMedGoogle Scholar
  • 31 Zwaal RF A, Hemker HC. Blood cell membranes and haemostasis. Haemostasis 1982; 11: 12-39
    PubMedGoogle Scholar
  • 32 Rauch J, Meng QH, Tannenbaum H. Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies. J Immunol 1987; 139: 2598-2604
    PubMedGoogle Scholar
  • 33 Faaber P, Rijke TP M, van de Putte LB A, Capel PJ A, Berden JH M. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. J Clin Invest 1986; 77: 1824-1830
    CrossrefPubMedGoogle Scholar
  • 34 Mikhail MH, Szczech LA M, Shapiro SS. The binding of lupus anticoagulants (LAC’s) to human platelets. Blood 1988; 72: 333 (Abstr)
    PubMedGoogle Scholar